More than 30% of people in the United States (US) are classified as obese, and over 50%
are considered significantly overweight. Importantly, obesity is a risk factor not only for the …

Introduction Sarcopenia is defined as a decline in muscle function as well as muscle mass.
Sarcopenia itself and sarcopenic obesity, defined as sarcopenia in obese patients, have …

Background The role of neoadjuvant immunochemotherapy (NICT) has gradually attracted
attention in recent years. To date, sensitive and reliable blood indicators to forecast the …

Background & aims Water, an essential component of body composition, appears to be a
significant predictor of adverse outcomes in clinical populations, despite being frequently …

Background: Pancreatic adenocarcinoma (PAAD) is a frequent digestive system cancer,
which has high mortality and bad outcome. However, the role of basement membrane (BM) …

Background High skeletal muscle mass might be a prognostic factor for patients with
pancreatic ductal adenocarcinoma (PDAC); however, the underlying reason is unclear. We …

While common pancreatic diseases, such as acute pancreatitis (AP), chronic pancreatitis
(CP), and pancreatic cancer (PC), may greatly impact the normal pancreatic physiology and …

Background: The association between pretreatment skeletal muscle index (SMI) and long-
term survival of pancreatic carcinoma patients remains unclear up to now. Methods: The …

Background/Aim: Sarcopenia, is predictive of a worse outcome after resection for colorectal
liver metastases (CRLM). Obesity leads to a metabolic double burden if sarcopenia is as …

Background Cancer-associated fibroblasts (CAFs) reportedly enhance the progression of
gastrointestinal surgery; however, the role of CAFs in ampullary carcinomas remains poorly …